Cargando…
Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts
BACKGROUND: Antigen recognition of allo-peptides and HLA molecules leads to the activation of donor-reactive T-cells following transplantation, potentially causing T-cell-mediated rejection (TCMR). Sequencing of the T-cell receptor (TCR) repertoire can be used to track the donor-reactive repertoire...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552542/ https://www.ncbi.nlm.nih.gov/pubmed/34721420 http://dx.doi.org/10.3389/fimmu.2021.750005 |
_version_ | 1784591396135501824 |
---|---|
author | Aschauer, Constantin Jelencsics, Kira Hu, Karin Heinzel, Andreas Gregorich, Mariella Gloria Vetter, Julia Schaller, Susanne Winkler, Stephan M. Weinberger, Johannes Pimenov, Lisabeth Gualdoni, Guido A. Eder, Michael Kainz, Alexander Troescher, Anna Regina Regele, Heinz Reindl-Schwaighofer, Roman Wekerle, Thomas Huppa, Johannes Bernhard Sykes, Megan Oberbauer, Rainer |
author_facet | Aschauer, Constantin Jelencsics, Kira Hu, Karin Heinzel, Andreas Gregorich, Mariella Gloria Vetter, Julia Schaller, Susanne Winkler, Stephan M. Weinberger, Johannes Pimenov, Lisabeth Gualdoni, Guido A. Eder, Michael Kainz, Alexander Troescher, Anna Regina Regele, Heinz Reindl-Schwaighofer, Roman Wekerle, Thomas Huppa, Johannes Bernhard Sykes, Megan Oberbauer, Rainer |
author_sort | Aschauer, Constantin |
collection | PubMed |
description | BACKGROUND: Antigen recognition of allo-peptides and HLA molecules leads to the activation of donor-reactive T-cells following transplantation, potentially causing T-cell-mediated rejection (TCMR). Sequencing of the T-cell receptor (TCR) repertoire can be used to track the donor-reactive repertoire in blood and tissue of patients after kidney transplantation. METHODS/DESIGN: In this prospective cohort study, 117 non-sensitized kidney transplant recipients with anti-CD25 induction were included. Peripheral mononuclear cells (PBMCs) were sampled pre-transplant and at the time of protocol or indication biopsies together with graft tissue. Next-generation sequencing (NGS) of the CDR3 region of the TCRbeta chain was performed after donor stimulation in mixed lymphocyte reactions to define the donor-reactive TCR repertoire. Blood and tissue of six patients experiencing a TCMR and six patients without rejection on protocol biopsies were interrogated for these TCRs. To elucidate common features of T-cell clonotypes, a network analysis of the TCR repertoires was performed. RESULTS: After transplantation, the frequency of circulating donor-reactive CD4 T-cells increased significantly from 0.86 ± 0.40% to 2.06 ± 0.40% of all CD4 cells (p < 0.001, mean dif.: -1.197, CI: -1.802, -0.593). The number of circulating donor-reactive CD4 clonotypes increased from 0.72 ± 0.33% to 1.89 ± 0.33% (p < 0.001, mean dif.: -1.168, CI: -1.724, -0.612). No difference in the percentage of donor-reactive T-cells in the circulation at transplant biopsy was found between subjects experiencing a TCMR and the control group [p = 0.64 (CD4(+)), p = 0.52 (CD8(+))]. Graft-infiltrating T-cells showed an up to six-fold increase of donor-reactive T-cell clonotypes compared to the blood at the same time (3.7 vs. 0.6% and 2.4 vs. 1.5%), but the infiltrating TCR repertoire was not reflected by the composition of the circulating TCR repertoire despite some overlap. Network analysis showed a distinct segregation of the donor-reactive repertoire with higher modularity than the overall TCR repertoire in the blood. These findings indicate an unchoreographed process of diverse T-cell clones directed against numerous non-self antigens found in the allograft. CONCLUSION: Donor-reactive T-cells are enriched in the kidney allograft during a TCMR episode, and dominant tissue clones are also found in the blood. TRIAL REGISTRATION: Clinicaltrials.gov: NCT: 03422224 (https://clinicaltrials.gov/ct2/show/NCT03422224). |
format | Online Article Text |
id | pubmed-8552542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85525422021-10-29 Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts Aschauer, Constantin Jelencsics, Kira Hu, Karin Heinzel, Andreas Gregorich, Mariella Gloria Vetter, Julia Schaller, Susanne Winkler, Stephan M. Weinberger, Johannes Pimenov, Lisabeth Gualdoni, Guido A. Eder, Michael Kainz, Alexander Troescher, Anna Regina Regele, Heinz Reindl-Schwaighofer, Roman Wekerle, Thomas Huppa, Johannes Bernhard Sykes, Megan Oberbauer, Rainer Front Immunol Immunology BACKGROUND: Antigen recognition of allo-peptides and HLA molecules leads to the activation of donor-reactive T-cells following transplantation, potentially causing T-cell-mediated rejection (TCMR). Sequencing of the T-cell receptor (TCR) repertoire can be used to track the donor-reactive repertoire in blood and tissue of patients after kidney transplantation. METHODS/DESIGN: In this prospective cohort study, 117 non-sensitized kidney transplant recipients with anti-CD25 induction were included. Peripheral mononuclear cells (PBMCs) were sampled pre-transplant and at the time of protocol or indication biopsies together with graft tissue. Next-generation sequencing (NGS) of the CDR3 region of the TCRbeta chain was performed after donor stimulation in mixed lymphocyte reactions to define the donor-reactive TCR repertoire. Blood and tissue of six patients experiencing a TCMR and six patients without rejection on protocol biopsies were interrogated for these TCRs. To elucidate common features of T-cell clonotypes, a network analysis of the TCR repertoires was performed. RESULTS: After transplantation, the frequency of circulating donor-reactive CD4 T-cells increased significantly from 0.86 ± 0.40% to 2.06 ± 0.40% of all CD4 cells (p < 0.001, mean dif.: -1.197, CI: -1.802, -0.593). The number of circulating donor-reactive CD4 clonotypes increased from 0.72 ± 0.33% to 1.89 ± 0.33% (p < 0.001, mean dif.: -1.168, CI: -1.724, -0.612). No difference in the percentage of donor-reactive T-cells in the circulation at transplant biopsy was found between subjects experiencing a TCMR and the control group [p = 0.64 (CD4(+)), p = 0.52 (CD8(+))]. Graft-infiltrating T-cells showed an up to six-fold increase of donor-reactive T-cell clonotypes compared to the blood at the same time (3.7 vs. 0.6% and 2.4 vs. 1.5%), but the infiltrating TCR repertoire was not reflected by the composition of the circulating TCR repertoire despite some overlap. Network analysis showed a distinct segregation of the donor-reactive repertoire with higher modularity than the overall TCR repertoire in the blood. These findings indicate an unchoreographed process of diverse T-cell clones directed against numerous non-self antigens found in the allograft. CONCLUSION: Donor-reactive T-cells are enriched in the kidney allograft during a TCMR episode, and dominant tissue clones are also found in the blood. TRIAL REGISTRATION: Clinicaltrials.gov: NCT: 03422224 (https://clinicaltrials.gov/ct2/show/NCT03422224). Frontiers Media S.A. 2021-10-14 /pmc/articles/PMC8552542/ /pubmed/34721420 http://dx.doi.org/10.3389/fimmu.2021.750005 Text en Copyright © 2021 Aschauer, Jelencsics, Hu, Heinzel, Gregorich, Vetter, Schaller, Winkler, Weinberger, Pimenov, Gualdoni, Eder, Kainz, Troescher, Regele, Reindl-Schwaighofer, Wekerle, Huppa, Sykes and Oberbauer https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Aschauer, Constantin Jelencsics, Kira Hu, Karin Heinzel, Andreas Gregorich, Mariella Gloria Vetter, Julia Schaller, Susanne Winkler, Stephan M. Weinberger, Johannes Pimenov, Lisabeth Gualdoni, Guido A. Eder, Michael Kainz, Alexander Troescher, Anna Regina Regele, Heinz Reindl-Schwaighofer, Roman Wekerle, Thomas Huppa, Johannes Bernhard Sykes, Megan Oberbauer, Rainer Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts |
title | Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts |
title_full | Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts |
title_fullStr | Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts |
title_full_unstemmed | Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts |
title_short | Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts |
title_sort | prospective tracking of donor-reactive t-cell clones in the circulation and rejecting human kidney allografts |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552542/ https://www.ncbi.nlm.nih.gov/pubmed/34721420 http://dx.doi.org/10.3389/fimmu.2021.750005 |
work_keys_str_mv | AT aschauerconstantin prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT jelencsicskira prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT hukarin prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT heinzelandreas prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT gregorichmariellagloria prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT vetterjulia prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT schallersusanne prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT winklerstephanm prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT weinbergerjohannes prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT pimenovlisabeth prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT gualdoniguidoa prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT edermichael prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT kainzalexander prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT troescherannaregina prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT regeleheinz prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT reindlschwaighoferroman prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT wekerlethomas prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT huppajohannesbernhard prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT sykesmegan prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts AT oberbauerrainer prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts |